These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12649189)

  • 21. Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
    Wong JY; Chu DZ; Williams LE; Yamauchi DM; Ikle DN; Kwok CS; Liu A; Wilczynski S; Colcher D; Yazaki PJ; Shively JE; Wu AM; Raubitschek AA
    Clin Cancer Res; 2004 Aug; 10(15):5014-21. PubMed ID: 15297402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein.
    Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O
    BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmapheresis in radioimmunotherapy of micrometastases: a mathematical modeling and dosimetrical analysis.
    Sgouros G
    J Nucl Med; 1992 Dec; 33(12):2167-79. PubMed ID: 1460511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of human melanoma tumor growth in severe combined immunodeficient mice by passive transfer of antibodies induced by a high molecular weight melanoma-associated antigen mimotope vaccine.
    Wagner S; Krepler C; Allwardt D; Latzka J; Strommer S; Scheiner O; Pehamberger H; Wiedermann U; Hafner C; Breiteneder H
    Clin Cancer Res; 2008 Dec; 14(24):8178-83. PubMed ID: 19088033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
    Biburger M; Weth R; Wels WS
    J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A one-step method for determining the maximum number of bound antibodies, and the affinity and association rate constants for antibody binding.
    Dahle J; Krogh C; Melhus KB; Kaalhus O; Larsen RH; Stokke T
    Nucl Med Commun; 2007 Sep; 28(9):742-7. PubMed ID: 17667754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody penetration into a spherical prevascular tumor nodule embedded in normal tissue.
    Banerjee RK; Sung C; Bungay PM; Dedrick RL; van Osdol WW
    Ann Biomed Eng; 2002 Jun; 30(6):828-39. PubMed ID: 12220082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunofluorescence imaging as a tool for studying the pharmacokinetics of a human monoclonal single chain fragment antibody.
    Ramjiawan B; Ariano RE; Mantsch HH; Maiti P; Jackson M
    IEEE Trans Med Imaging; 2002 Oct; 21(10):1317-23. PubMed ID: 12585714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions.
    Glicklis R; Merchuk JC; Cohen S
    Biotechnol Bioeng; 2004 Jun; 86(6):672-80. PubMed ID: 15137079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Redesigning an antibody fragment for faster association with its antigen.
    Marvin JS; Lowman HB
    Biochemistry; 2003 Jun; 42(23):7077-83. PubMed ID: 12795603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
    J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of antibody affinity and antigen valence on molecular forms of immune complexes.
    Oda M; Uchiyama S; Noda M; Nishi Y; Koga M; Mayanagi K; Robinson CV; Fukui K; Kobayashi Y; Morikawa K; Azuma T
    Mol Immunol; 2009 Dec; 47(2-3):357-64. PubMed ID: 19800690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
    Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-affinity binding measurements of antibodies to cell-surface-expressed antigens.
    Rathanaswami P; Babcook J; Gallo M
    Anal Biochem; 2008 Feb; 373(1):52-60. PubMed ID: 17910940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB.
    Pollack VA; Alvarez E; Tse KF; Torgov MY; Xie S; Shenoy SG; MacDougall JR; Arrol S; Zhong H; Gerwien RW; Hahne WF; Senter PD; Jeffers ME; Lichenstein HS; LaRochelle WJ
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):423-35. PubMed ID: 17541593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies and gene therapy: teaching old 'magic bullets' new tricks.
    Sanz L; Blanco B; Alvarez-Vallina L
    Trends Immunol; 2004 Feb; 25(2):85-91. PubMed ID: 15102367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
    Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental design for analysis of complex kinetics using surface plasmon resonance.
    Lipschultz CA; Li Y; Smith-Gill S
    Methods; 2000 Mar; 20(3):310-8. PubMed ID: 10694453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy.
    Zitzmann S; Mier W; Schad A; Kinscherf R; Askoxylakis V; Krämer S; Altmann A; Eisenhut M; Haberkorn U
    Clin Cancer Res; 2005 Jan; 11(1):139-46. PubMed ID: 15671538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.